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Role of a BRCT domain in the interaction of DNA ligase III-a with
the DNA repair protein XRCC1
Richard M. Taylor, Bill Wickstead, Sam Cronin and Keith W. Caldecott
The BRCT domain (for BRCA1 carboxyl terminus) is a
protein motif of unknown function, comprising
approximately 100 amino acids in five conserved blocks
denoted A–E. BRCT domains are present in the tumour
suppressor protein BRCA1 [1—3], and the domain is
found in over 40 other proteins, defining a superfamily
that includes DNA ligase III-a and the essential human
DNA repair protein XRCC1. DNA ligase III-a and XRCC1
interact via their carboxyl termini, close to or within
regions that contain a BRCT domain [4]. To examine
whether the primary role of the carboxy-terminal BRCT
domain of XRCC1 (denoted BRCT II) is to mediate the
interaction with DNA ligase III-a, we identified the
regions of the domain that are required and sufficient for
the interaction. An XRCC1 protein in which the conserved
D-block tryptophan was disrupted by point mutation
retained the ability to interact with DNA ligase III-a, so
this tryptophan must mediate a different, although
conserved, role. XRCC1 in which the weakly conserved 
C-block was mutated lost the ability to interact with DNA
ligase III-a. Moreover, 20 amino acids spanning the 
C-block of BRCT II conferred full DNA ligase III-a binding
activity upon an unrelated polypeptide. An XRCC1 protein
in which this 20mer was deleted could not maintain
normal levels of DNA ligase III-a in transfected rodent
cells, a phenotype associated with defective repair [5]. In
summary, these data demonstrate that a BRCT domain
can mediate a biologically important protein—protein
interaction, and support the existence of additional roles.
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Results and discussion
To test the proposal that BRCT domains serve to mediate
protein–protein interactions [1,2,6], we have disrupted a
BRCT domain. We generated targeted deletions and point
mutations within the BRCT II domain of XRCC1 to iden-
tify the motifs that are required and sufficient for the 
interaction of XRCC1 with DNA ligase III-α [4,7,8]. Wild-
type and mutant histidine (His)-tagged human XRCC1
polypeptides were purified from Escherichia coli and com-
pared for their ability to interact with human DNA ligase
III-α by ‘pull-down’ assays and ‘far-western’ blotting
(Figure 1). The interaction of DNA ligase III-α with a
truncated XRCC1 polypeptide, XRCC11–592, was reduced
fivefold compared with full-length XRCC1, and the inter-
action of DNA ligase III-α with two other truncated
XRCC1 molecules, XRCC11–573 and XRCC1∆575–589, was
reduced more than 30-fold (Figure 1b). These results indi-
cate that the region of BRCT II downstream of amino acid
573 is important for interaction with DNA ligase III-α, and
that the region between residues 573 and 592 is critical for
this interaction. Residues 573–592 span the C-block motif
of BRCT II, which is one of the five conserved blocks
(Figure 1) [1,2]. The importance of the C-block for inter-
action with DNA ligase III-α was confirmed by the activ-
ity of the XRCC1VI584/585DD polypeptide, in which two of
the non-charged residues characteristic of C-block motifs
were substituted with aspartate. This mutant had less than
3% of the DNA ligase III-α binding activity exhibited by
wild-type XRCC1 (Figure 1b). In contrast, substitution of
the D-block residue Trp611 with aspartate (XRCC1W611D)
did not significantly disrupt the interaction with DNA
ligase III-α (Figure 1b). It is intriguing that Trp611 is dis-
pensable, as it is one of the two most conserved amino
acids in BRCT domains and is a defining feature of the 
D-block motif, which is itself the most conserved motif in
BRCT domains [1,2].
These results indicate that the C-block motif of BRCT II is
critical for the interaction of XRCC1 with DNA ligase III-α.
To examine whether the C-block is sufficient for interaction
with DNA ligase III-α, a peptide comprising the 20 amino
acids that span this region was tested for its ability to confer
the property of binding the DNA ligase upon an unrelated
polypeptide. An oligonucleotide duplex encoding residues
573–592 of XRCC1 was cloned into the E. coli expression
vector pMAL-cR1 downstream of an open reading frame
(ORF) encoding the bacterial maltose binding protein
(MBP). The resulting construct encoded a tripartite
polypeptide comprising MBP, XRCC1573–592 and the α-
fragment of β-galactosidase  (Figure 2a). This polypeptide,
denoted MBP–X573–592, was compared with one expressed
from the pMAL-cR1 vector (MBP–β-galactosidase α,
denoted MBP, Figure 2a) for the ability to interact with His-
tagged DNA ligase III-α immobilised on agarose beads in a
pull-down assay. His–DNA ligase III-α bound to agarose
was incubated with either MBP or MBP–X573–592 and the
beads recovered by centrifugation. After extensive washing,
His–DNA ligase III-α and any associated MBP fusion pro-
teins were fractionated by SDS–PAGE and detected by
immunoblotting (with anti-MBP antisera) or staining with
Coomassie blue. These experiments revealed that 25-fold
more MBP–X573–592 than MBP was bound by His–DNA
ligase III-α (Figure 2b, left panel). In control experiments,
MBP–X573–592 was not bound by the agarose beads in the
absence of His–DNA ligase III-α (data not shown). Staining
for total protein suggested that His–DNA ligase III-α and
MBP–X573–592 were recovered in approximately stoichio-
metric amounts, suggesting that His–DNA ligase III-α was
fully bound by MBP–X573–592 (Figure 2b, right panel). To
quantitate the relative binding efficiency of MBP–X573–592
with DNA ligase III-α, we compared the behaviour of
MBP–X573–592 with MBP fused to full-length XRCC1
(denoted MBP–X [8]) in a pull-down assay. MBP–X573–592
and MBP–X bound to His–DNA ligase III-α on agarose
beads with equal efficiency (Figure 2c), indicating that the
20mer peptide spanning the C-block is sufficient for full
DNA ligase III-α binding activity when inserted into MBP.
The behaviour of the XRCC1 protein that had BRCT II
sequences carboxy-terminal to the C-block deleted
(XRCC11–592) had suggested that this carboxy-terminal
region significantly influences interaction with DNA ligase
III-α (Figure 1b). It is possible that the region carboxy-ter-
minal to the C-block normally places the C-block in a
context suitable for interaction, a role which when the 
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Amino acids spanning the C-block of BRCT II are required for
interaction with DNA ligase III-α. (a) The BRCT domains present in
BRCA1 and XRCC1 are aligned as previously depicted [2]; conserved
blocks A–E are boxed and the numbers of residues between blocks
are indicated. Underlined residues were targeted for substitution
mutation, as depicted in (b). (b) The interaction of mutant XRCC1
molecules with DNA ligase III-α measured by pull-down assays and far-
western blotting. The BRCT II amino-acid residues (aa) and conserved
blocks mutated by substitution or deletion are indicated. For far-
western blots, radiolabeled XRCC1 polypeptides were incubated with
nitrocellulose blots containing DNA ligase III-α previously fractionated
by SDS–PAGE and protein complexes were detected by
autoradiography. For pull-down assays, His–XRCC1 bound to agarose
beads and DNA ligase III-α polypeptides were mixed to facilitate
protein–protein interactions and protein complexes recovered by
centrifugation. XRCC1 and DNA ligase III polypeptides were detected
on immunoblots with appropriate antibodies used individually or in
combination. The positions of XRCC1 (X) and DNA ligase III-α (ligIII)
polypeptides are indicated. The efficiency of interaction with DNA
ligase III-α is indicated for each XRCC1 polypeptide, as a percentage
relative to full-length XRCC1, and is the average of values obtained
from multiple pull-down and far-western experiments. Values indicated
by an asterisk are maximum estimates, as the measurement of interaction
efficiencies below 3% was beyond the sensitivity of the assays.
C-block region is inserted into MBP is either not required or
is fulfilled by the β-galactosidase fragment.
To examine the specificity of the interaction between
His–DNA ligase III-α and MBP–X573–592, we determined
whether MBP–X573–592 bound His–DNA ligase III-α within
the same region bound by full-length XRCC1. We used a
preparation of recombinant His–DNA ligase III-α that con-
tained truncated His–DNA ligase III-α polypeptides
lacking the normal carboxyl terminus, in addition to con-
taining the full-length protein (see Figure 2d legend). We
reasoned that because full-length XRCC1 interacts with the
carboxyl terminus of DNA ligase III-α, MBP–X573–592
should bind only full-length DNA ligase III-α if it also
targets the carboxyl terminus. Indeed, full-length DNA
ligase III-α was efficiently separated from the truncated
polypeptides by MBP–X573–592 bound to agarose beads in a
pull-down assay (Figure 2d).
The XRCC1 mutant CHO cell lines EM9 and EM-C11
possess reduced levels (4–6-fold) of DNA ligase III-α
protein and cannot efficiently rejoin DNA single-strand
breaks arising from ionising radiation and certain alkylating
agents [5,7–10]. Moreover, EM-C11 cell extract cannot effi-
ciently ligate DNA single-strand breaks during DNA base-
excision repair in vitro, a deficiency that is complemented
by the addition of recombinant DNA ligase [5]. To examine
whether the C-block of BRCT II is required to maintain
normal cellular levels of DNA ligase III-α and consequently
required for normal DNA repair, we compared XRCC1 and
XRCC1∆575–589 proteins for their ability to increase the level
of DNA ligase III-α in EM9 transfectants. Immunoblots
probed with anti-DNA ligase III polyclonal antibody
revealed that whereas full-length XRCC1 did increase
DNA ligase III-α to normal levels, XRCC1∆575–589 failed to
elevate the level of the ligase above levels present in EM9
cells transfected with ‘empty’ vector (Figure 3 and data not
Brief Communication 879
Figure 2
Unbound
MBP
MBP–X573–592

LEDYMSDR VQFVIT AQEWDP
β-gal
MBP
MBP
(a)
Mix Bound
(b)
(c)
100
 kDa
60
Current Biology   
Mix BoundWash Wash
Bound BoundWash 3Wash 2Wash 1Mix
M
BP
–X
57
3–
59
2
M
BP
–X
57
3–
59
2
M
BP
–X
57
3–
59
2
M
BP
–X
57
3–
59
2
M
BP
M
BP
–X
57
3–
59
2
M
BP
M
BP
M
BP
Bound
(d)Mix Bound Interaction
(%)MBP–X
(112 kDa)
MBP–X573–592
(53 kDa)
100
 97
LigIII (100 kDa)


MBP–X573–592
53 kDa
51 kDa

β-gal
A 20mer peptide module that spans the C-block of BRCT II is sufficient
for full and specific interaction with DNA ligase III-α when inserted into
an unrelated polypeptide. (a) A diagram of MBP–X573–592 and MBP is
on the left with the 20mer peptide boxed in blue. The highlighted
VQFVIT sequence defines the C-block within the BRCT domain, the
rest is flanking sequence. The recombinant proteins following
purification from E. coli, SDS–PAGE and staining with Coomassie blue
are shown on the right. (b) MBP–X573–592 binds DNA ligase III-α
stoichiometrically in pull-down assays. DNA ligase III-α immobilised on
agarose beads was mixed with MBP or MBP–X573–592 and the
agarose–protein complexes were recovered by centrifugation. Aliquots
sampled during the experiment were subjected to SDS–PAGE. DNA
ligase III-α (ligIII) was detected with Coomassie blue and MBP fusion
proteins with either anti-MBP antisera (left panel) or Coomassie blue
(right panel). Aliquots on the left panel are DNA ligase III-α agarose
beads and MBP or MBP–X573–592 (mix), samples recovered from the
last agarose-bead wash (wash), and DNA ligase III-α agarose beads
with any associated MBP fusion proteins (bound). On the right panel,
the total protein (Coomassie blue staining) in an aliquot from the
MBP–X573–592 pull-down (bound) is shown to examine stoichiometry.
(c) MBP–X573–592 and MBP–X bind His–DNA ligase III-α with equal
efficiency. MBP–X573–592 was compared with MBP–X for the ability to
bind His–DNA ligase III-α in a pull-down assay. Aliquots of the ‘mix’ and
‘bound’ samples are shown following SDS–PAGE and immunoblotting
with anti-MBP antisera. The efficiency (%) at which MBP–X573–592
interacts with His–DNA ligase III-α relative to MBP–X is shown.
(d) MBP–X573–592 binds the carboxyl terminus of His–DNA ligase III-α.
In addition to full-length His–DNA ligase III-α, a mixture of carboxy-
terminal-truncated polypeptides are generated when this protein is
expressed in E. coli at high levels due to incomplete translation. Such a
preparation was mixed with MBP–X573–592 agarose beads and
agarose–protein complexes were recovered by centrifugation. Included
on the gel were samples of MBP–X573–592 agarose beads and
His–DNA ligase III-α polypeptides (mix), samples containing
polypeptides that failed to bind MBP–X573–592 beads (unbound),
samples recovered from the last three agarose-bead washes (wash), and
samples containing polypeptides eluted from MBP–X573–592 beads with
1 M NaCl (bound). The positions of full-length and truncated His–DNA
ligase III-α polypeptides are indicated by arrows on the left-hand side.
shown). Thus, the C-block motif of BRCT II is required to
maintain normal cellular levels of DNA ligase III-α. 
The results described here demonstrate that the BRCT II
domain of XRCC1 facilitates the physical interaction of this
essential DNA repair protein with DNA ligase III-α and
indicate that this interaction is required to maintain normal
cellular levels of the ligase. These data thus demonstrate
that the BRCT II domain facilitates a biologically important
protein–protein interaction, and support the hypothesis that
the role of BRCT domains is to mediate such interactions
[1,2,6]. It seems likely, however, that BRCT II also fulfils
another role, as it is unlikely that such a large and complex
structure is required solely for interaction with DNA ligase
III-α. Consistent with this, the highly conserved tryptophan
that in part defines the D-block of BRCT domains was dis-
pensable for this interaction. Thus, it is likely that at least
some amino acids located carboxy-terminal to the C-block
in BRCT II fulfil another role, which is conserved in other
BRCT domains. One possibility is that they have a role in
signal transduction. For example, each BRCT domain
could mediate an interaction that is unique to that domain
(for example, via the weakly conserved C-block motif) in
combination with an interaction that is common to all
domains (for example, via the highly conserved D-block
motif). In this scenario, BRCT domains could behave as
adaptor molecules capable of linking different cellular
processes (such as DNA repair and cell cycle control) to a
common or related signal transduction pathway.
Materials and methods
Far-western blotting was conducted as described [8,11]. Briefly,
recombinant human XRCC1 was phosphorylated with casein kinase II
(Boehringer Mannheim) in the presence of γ-[32P]ATP. Labelled
XRCC1 probes (1 µg at 50 ng/ml) were incubated with nitrocellulose
blots containing renatured human DNA ligase III-α that had previously
been fractionated by SDS–PAGE. XRCC1–DNA ligase III-α com-
plexes were detected by autoradiography. Pull-down assays were con-
ducted as described [4,8,11]. Briefly, His–DNA ligase III-α (1 nM) or
His–XRCC1 (1 nM) bound to nickel–NTA agarose beads, or
MBP–X573–592 (1 nM) bound to agarose beads, were incubated with
purified MBP fusion proteins (1 nM), DNA ligase III-α (~1 nM) in E. coli
extract, or a heterogeneous mixture of purified His–DNA ligase III-α
polypeptides (1 nM), respectively. After 20–30 min, agarose beads
were recovered by low-speed centrifugation, washed extensively, and
bead-bound proteins eluted with 200 mM imidazole for nickel–NTA
agarose complexes, or 1 M NaCl for agarose–MBP–X573–592 com-
plexes. Following SDS–PAGE, gels were stained with Coomassie blue
to detect total protein or with appropriate antibodies (singly or in com-
bination) to detect XRCC1 and MBP fusion proteins. In control experi-
ments, the XRCC1 mutations described did not affect the interaction of
XRCC1 with DNA polymerase-β, a polypeptide that interacts with
XRCC1 outside the BRCT II domain ([12,13] and data not shown).
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Figure 3
XRCC1∆575–589 fails to correct the reduced levels of DNA ligase III-α
in EM9 cells. Total cell extract from stable EM9 transfectants
harbouring either pcD2E vector (EM9-2E), pcD2EX encoding full-
length XRCC1 (EM9-X), or pcD2EX∆575–589 encoding
XRCC1∆575–589 (EM9-X∆575–589) were fractionated by SDS–PAGE.
Fractionated polypeptides were either stained with Coomassie blue
(top panel) or transferred to nitrocellulose and immunoblotted with an
anti-DNA ligase III (ligIII) antibody (bottom panel). The level of DNA
ligase III-α present in the EM9-X cell extract is similar to that present in
an extract from wild-type parental AA8 cells ([8] and data not shown).
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